First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT01521715 · COMPLETED

Trial details

NCT number: NCT01521715
Sponsor: iOMEDICO AG
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Locally Advanced and/or Metastatic Renal Cell Carcinoma Carcinoma, Renal Cell Clear-cell Metastatic Renal Cell Carcinoma

Start date: 2012-01-24
Primary completion: 2017-06-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.